Cargando…

ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer’s disease models

Predisposition to Alzheimer’s disease (AD) may arise from lipid metabolism perturbation, however, the underlying mechanism remains elusive. Here, we identify ATPase family AAA-domain containing protein 3A (ATAD3A), a mitochondrial AAA-ATPase, as a molecular switch that links cholesterol metabolism i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yuanyuan, Hu, Di, Wang, Rihua, Sun, Xiaoyan, Ropelewski, Philip, Hubler, Zita, Lundberg, Kathleen, Wang, Quanqiu, Adams, Drew J., Xu, Rong, Qi, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891325/ https://www.ncbi.nlm.nih.gov/pubmed/35236834 http://dx.doi.org/10.1038/s41467-022-28769-9

Ejemplares similares

Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer’s disease
por: Zhang, Xinwen, et al.
Publicado: (2020)

ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects
por: Zhao, Yuanyuan, et al.
Publicado: (2019)

Small-molecule suppression of calpastatin degradation reduces neuropathology in models of Huntington’s disease
por: Hu, Di, et al.
Publicado: (2021)

Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
por: Xu, Jiqing, et al.
Publicado: (2016)

Nano‐Brake Halts Mitochondrial Dysfunction Cascade to Alleviate Neuropathology and Rescue Alzheimer's Cognitive Deficits
por: Zhang, Qian, et al.
Publicado: (2023)

Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
por: Xu, Rong, et al.
Publicado: (2016)

Aminostyrylbenzofuran Directly Reduces Oligomeric Amyloid-β and Reverses Cognitive Deficits in Alzheimer Transgenic Mice
por: Lee, Sang-Hyun, et al.
Publicado: (2014)

Cognitive deficits and Alzheimer-like neuropathological impairments during adolescence in a rat model of type 2 diabetes mellitus
por: Jin, Li, et al.
Publicado: (2018)

Blame ATAD5 for factory closures
por: Leslie, Mitch
Publicado: (2013)

Cognitive resilience and severe Alzheimer’s disease neuropathology
por: Ahangari, Narges, et al.
Publicado: (2023)

Lamotrigine protects against cognitive deficits, synapse and nerve cell damage, and hallmark neuropathologies in a mouse model of Alzheimer’s disease
por: Fu, Xin-Xin, et al.
Publicado: (2022)

The neuropathological diagnosis of Alzheimer’s disease
por: DeTure, Michael A., et al.
Publicado: (2019)

Fragment-Based Screening of the Bromodomain of ATAD2
por: Harner, Mary J., et al.
Publicado: (2014)

Hospitalization, Alzheimer's Disease and Related Neuropathologies, and Cognitive Decline
por: James, Bryan D., et al.
Publicado: (2019)

Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
por: Uretsky, Madeline, et al.
Publicado: (2021)

Cognitive reserve, neuropathology, and progression towards Alzheimer’s disease
por: Nelson, Monica E., et al.
Publicado: (2023)

ATAD2 controls chromatin-bound HIRA turnover
por: Wang, Tao, et al.
Publicado: (2021)

Progranulin mutations in clinical and neuropathological Alzheimer's disease
por: Vardarajan, Badri N., et al.
Publicado: (2022)

Chronic diabetic states worsen Alzheimer neuropathology and cognitive deficits accompanying disruption of calcium signaling in leptin-deficient APP/PS1 mice
por: Zhang, Shuai, et al.
Publicado: (2017)

The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia
por: Tasaki, Shinya, et al.
Publicado: (2018)

Age-dependent postoperative cognitive impairment and Alzheimer-related neuropathology in mice
por: Xu, Zhipeng, et al.
Publicado: (2014)

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development
por: Rabinovici, Gil D., et al.
Publicado: (2016)

Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
por: Chang, Yanmin, et al.
Publicado: (2021)

Tumor-Promoting ATAD2 and Its Preclinical Challenges
por: Liu, Haicheng, et al.
Publicado: (2022)

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
por: Smirnov, Denis S., et al.
Publicado: (2022)

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
por: Esposito, Michelle, et al.
Publicado: (2019)

Illustrated Neuropathologic Diagnosis of Alzheimer’s Disease
por: Doher, Nicholas, et al.
Publicado: (2023)

Treatment Combining Focused Ultrasound with Gastrodin Alleviates Memory Deficit and Neuropathology in an Alzheimer's Disease-Like Experimental Mouse Model
por: Luo, Kaixuan, et al.
Publicado: (2022)

Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain
por: Evans, Chiara M., et al.
Publicado: (2021)

NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
por: Thatcher, Gregory RJ, et al.
Publicado: (2013)

Isoflurane mediated neuropathological and cognitive impairments in the triple transgenic Alzheimer’s mouse model are associated with hippocampal synaptic deficits in an age-dependent manner
por: Joseph, Donald J., et al.
Publicado: (2019)

Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer’s disease via inhibiting neuropathology and modulating gut microbiota
por: Qu, Chang, et al.
Publicado: (2021)

Corrigendum: Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
por: Chang, Yanmin, et al.
Publicado: (2021)

C. elegans ATAD-3 Is Essential for Mitochondrial Activity and Development
por: Hoffmann, Michael, et al.
Publicado: (2009)

Congenital immobility and stiffness related to biallelic ATAD1 variants
por: Bunod, Roxane, et al.
Publicado: (2020)

Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
por: Yang, Wenjuan, et al.
Publicado: (2018)

Bergenin ameliorates cognitive deficits and neuropathological alterations in sodium azide-induced experimental dementia
por: Singla, Rajeev K., et al.
Publicado: (2022)

Yeast-Based Aβ1-15 Vaccine Elicits Strong Immunogenicity and Attenuates Neuropathology and Cognitive Deficits in Alzheimer’s Disease Transgenic Mice
por: Liu, Dong-qun, et al.
Publicado: (2020)

A CHCHD6–APP axis connects amyloid and mitochondrial pathology in Alzheimer’s disease
por: Shang, Yutong, et al.
Publicado: (2022)

Predisposition to Cancer Caused by Genetic and Functional Defects of Mammalian Atad5
por: Bell, Daphne W., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nihfe6bs8hfcg1ms9oj5j1ev4v